Clinical Trial Update: Intra-arterial Infusion of Autologous Bone Marrow Mononuclear Cells in Non-diabetic Patients With Critical Limb Ischemia (CLI). [Phase 2]

View source ↗

Summary

Phase 2 trial update on intra-arterial infusion of autologous bone marrow mononuclear cells in non-diabetic patients with critical limb ischemia; the study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia

Drugs mentioned

• Autologous bone marrow mononuclear cell infusion (bone marrow mononuclear cells)

Snippet

Sponsor: Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | Conditions: Critical Limb Ischemia (CLI) | Phase 2 | Status: COMPLETED